Abiraterone

Drug Details

Abiraterone, also known by the brand name Zytiga, is an oral medication prescribed for treating specific types of prostate cancer. This drug functions by inhibiting the production of testosterone, a male hormone that fuels the growth and spread of prostate cancer cells. Taking abiraterone requires concurrent administration of a steroid, typically once or twice daily. Additionally, patients may need to take another medication that affects gonadotropin-releasing hormone (GnRH), unless they have undergone a bilateral orchiectomy, which is the surgical removal of both testicles. Abiraterone is especially beneficial for cancers that rely on testosterone for growth, as well as those that can persist in low testosterone conditions. Common side effects include high blood pressure and fluid retention leading to swelling. While Zytiga is available as a more affordable generic option, Yonsa, another brand, is not. It is important for patients to consult with healthcare professionals, such as doctors, nurses, or pharmacists, before starting abiraterone or any other medications, including over-the-counter drugs or supplements. This medication is not intended for use in women or children.